Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 08, 2023

SELL
$4.28 - $6.57 $1,553 - $2,384
-363 Reduced 1.54%
23,262 $100,000
Q2 2023

Jul 28, 2023

SELL
$5.9 - $6.95 $40,704 - $47,948
-6,899 Reduced 22.6%
23,625 $156,000
Q1 2023

May 15, 2023

SELL
$6.18 - $7.99 $667 - $862
-108 Reduced 0.35%
30,524 $207,000
Q4 2022

Feb 07, 2023

SELL
$6.87 - $10.96 $44,126 - $70,396
-6,423 Reduced 17.33%
30,632 $226,000
Q3 2022

Nov 14, 2022

SELL
$9.44 - $11.76 $91,681 - $114,213
-9,712 Reduced 20.77%
37,055 $366,000
Q2 2022

Aug 09, 2022

BUY
$9.31 - $11.84 $735 - $935
79 Added 0.17%
46,767 $510,000
Q1 2022

May 04, 2022

SELL
$10.84 - $16.55 $74,893 - $114,343
-6,909 Reduced 12.89%
46,688 $528,000
Q4 2021

Feb 09, 2022

BUY
$15.69 - $21.14 $3,828 - $5,158
244 Added 0.46%
53,597 $841,000
Q3 2021

Nov 04, 2021

SELL
$15.35 - $21.27 $35,305 - $48,921
-2,300 Reduced 4.13%
53,353 $914,000
Q2 2021

Aug 12, 2021

BUY
$15.71 - $21.51 $184,639 - $252,807
11,753 Added 26.77%
55,653 $1.2 Million
Q1 2021

May 10, 2021

BUY
$13.42 - $20.28 $161,952 - $244,739
12,068 Added 37.91%
43,900 $659,000
Q4 2020

Feb 16, 2021

BUY
$9.77 - $13.81 $213,376 - $301,610
21,840 Added 218.57%
31,832 $418,000
Q2 2020

Aug 10, 2020

BUY
$9.66 - $12.02 $96,522 - $120,103
9,992 New
9,992 $114,000
Q4 2017

Feb 09, 2018

SELL
$12.85 - $18.1 $387,658 - $546,040
-30,168 Closed
0 $0
Q3 2017

Oct 20, 2017

BUY
$15.4 - $18.85 $464,587 - $568,666
30,168
30,168 $540,000

Others Institutions Holding VNDA

About Vanda Pharmaceuticals Inc.


  • Ticker VNDA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 56,561,500
  • Market Cap $274M
  • Description
  • Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...
More about VNDA
Track This Portfolio

Track Shell Asset Management CO Portfolio

Follow Shell Asset Management CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Shell Asset Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Shell Asset Management CO with notifications on news.